ESC 365 - The SGLT-2 inhibitor empagliflozin improves myocardial strain,ejection fraction, reduces pro-inflammatory cytokines and H-FABP/troponin in models of anthracyline-induced cardiotoxicity

Delegates Premium Access

The SGLT-2 inhibitor empagliflozin improves myocardial strain,ejection fraction, reduces pro-inflammatory cytokines and H-FABP/troponin in models of anthracyline-induced cardiotoxicity

Session: Imaging in cardio-oncology

Topic: Myocardial Disease

Speaker: Doctor N. Maurea (Naples, IT)

Event: EuroEcho-Imaging 2024

Congress Presentation

Add to my library

About the speaker

Doctor Nicola Maurea

National Cancer Institute G.Pascale Foundation IRCCS, Naples (Italy)

3 presentations

2 followers

4 more presentations in this session

Association of echocardiographic radiomics-based features with cardiotoxicity effect in breast cancer patients from the CARDIOCARE project

Speaker: Assistant Professor L. Lakkas (Ioannina, GR)

Natural shear wave elastography reveals hidden cardiac dysfunction in adult survivors of childhood cancer during cardiopulmonary stress testing

Speaker: Doctor A. Youssef (Leuven, BE)

Oxidative stress biomarkers and myocardial dysfunction in a doxorubicin- and trastuzumab-induced rat model of cardiomyopathy

Speaker: Associate Professor D. Cho (Seoul, KR)

Right ventricular strain as a predictor of trastuzumab-induced chemotherapy-related cardiac dysfunction: a meta-analysis

Speaker: Doctor I. Scott (Newcastle Upon Tyne, GB)

Access the full session

Imaging in cardio-oncology

Speakers: Doctor N. Maurea, Assistant Professor L. Lakkas, Doctor A. Youssef, Associate Professor D. Cho, Doctor I. Scott

About the event

EuroEcho-Imaging 2024

11 December - 13 December 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources